Heres comprehensive guidance on minimizing risks and ensuring appropriate use
Registered clinical trial listings for ongoing retatrutide research: ClinicalTrials.gov retatrutide listings
Findings show that GLP-1 use changes not just how much people eat, but also what kinds of food they choose
J Neural Transm 104:661677 Saharan S, Mandal PK (2014) The emerging role of glutathione in Alzheimer's disease
Most prescribing guidelines recommend the medications for adults with a body mass index of 30 or greater, or at least 27 with obesity-related health conditions such as high blood pressure, Type 2 diabetes or sleep apnea
A 9.9b In adults with type 2 diabetes, obesity, and symptomatic HFpEF, the glucose-lowering treatment plan should include a GLP-1 RA with demonstrated benefits for HF-related symptoms A and/or reduction in HF events (irrespective of A1C)